Related references
Note: Only part of the references are listed.Triple negative breast cancer: A thorough review of biomarkers
Jesse Lopes da Silva et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
An NAD+-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39
Ling Dong et al.
ISCIENCE (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Recent therapeutic trends and promising targets in triple negative breast cancer
Soo-Yeon Hwang et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx
Mohamed Mounir et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
Jing Zhai et al.
CANCER LETTERS (2019)
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer
Yulia Liubomirski et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
Wei-Siang Liao et al.
ACTA BIOMATERIALIA (2019)
Recent advances in breast cancer research impacting clinical diagnostic practice
Amy E. McCart Reed et al.
JOURNAL OF PATHOLOGY (2019)
Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer
Rosa Mistica C. Ignacio et al.
Oncotarget (2019)
USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis
Ling Dong et al.
ONCOGENE (2018)
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Jhajaira M. Araujo et al.
SCIENTIFIC REPORTS (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
Mohammad M. Uddin et al.
PLOS ONE (2018)
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M. M-Rabet et al.
ANNALS OF ONCOLOGY (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
Breast Cancer: Current Molecular Therapeutic Targets and New Players
Siddavaram Nagini
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Carlos Alfaro et al.
CANCER TREATMENT REVIEWS (2017)
Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)
Lironne Wein et al.
BREAST (2017)
MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells
Sangmin Kim et al.
TUMOR BIOLOGY (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Therapeutic targets of triple-negative breast cancer: a review
Vinayak S. Jamdade et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Zhen Ning Wee et al.
NATURE COMMUNICATIONS (2015)
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
Jagdeep K. Singh et al.
CLINICAL CANCER RESEARCH (2013)
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
Zhi Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
Sharon R. Pine et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8
Kongming Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor
Davis Sean et al.
BIOINFORMATICS (2007)
Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer
Balrai Singh et al.
JOURNAL OF SURGICAL RESEARCH (2006)
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors
E Azenshtein et al.
CANCER LETTERS (2005)
Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy
D Chelouche-Lev et al.
EUROPEAN JOURNAL OF CANCER (2004)
Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress
Philip L. Marjon et al.
MOLECULAR CANCER (2004)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Normalization of cDNA microarray data
GK Smyth et al.
METHODS (2003)
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation
YH Yang et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
